Scarica l'app Stockscreener
13.02
3.42%
0.43
Precedente Chiudi:
$12.59
Aprire:
$12.5
Volume 24 ore:
8.35M
Relative Volume:
3.22
Capitalizzazione di mercato:
$1.36B
Reddito:
$64.52M
Utile/perdita netta:
$-95.55M
Rapporto P/E:
-12.80
EPS:
-1.0169
Flusso di cassa netto:
$-84.65M
1 W Prestazione:
+23.53%
1M Prestazione:
+45.64%
6M Prestazione:
+59.95%
1 anno Prestazione:
+104.40%
Intervallo 1D:
$12.26
$13.37
Intervallo di 1 settimana:
$9.65
$13.37
Portata 52W:
$3.84
$13.37
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, A, NTRA
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
13.02 | 1.32B | 64.52M | -95.55M | -84.65M | -1.0169 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Personalis CEO Christopher Hall sells $1.31m in company stock By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $675,488 in company stock - Investing.com
Form 4 Personalis Inc For: 26 June By Investing.com - Investing.com UK
Personalis (PSNL) CFO uses 10b5-1 plan to exercise options and sell shares - Stock Titan
Personalis (PSNL) CEO sells 100K shares after exercising options - Stock Titan
Form 144 Personalis For: 26 June By Investing.com - Investing.com Canada
PSNL: Form 144 lists 51,251 shares to be sold; prior 10b5-1 sales noted - Stock Titan
Broker files Form 144 as Christopher Hall sells 100,000 PSNL shares (PSNL) - Stock Titan
Personalis, Inc. Actuals & Estimates (NASDAQ:PSNL) - TradingView
PSNL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Personalis, Inc. – NASDAQ:PSNL - TradingView
Personalis stock hits 52-week high at 12.53 USD By Investing.com - Investing.com South Africa
Personalis stock hits 52-week high at 12.53 USD - Investing.com
Personalis Inc (PSNL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Why Personalis Stock Is Rising: Medicare Covers Lung Cancer MRD Test - Stocktwits
Personalis Inc (PSNL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Numerous Personalis Insiders Sold Stock: Not A Positive Omen - 富途牛牛
Q1 2026 Personalis Inc Earnings Call Transcript - GuruFocus
Personalis Inc (PSNL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Personalis Inc (PSNL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Personalis Inc (PSNL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Personalis Inc (PSNL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Personalis Inc (PSNL) Institutional Confidence - TradingKey
Personalis Inc (PSNL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Personalis Inc (PSNL) Valuation: PE, PB & Fair Value Analysis - TradingKey
PSNL Q1 2026 Earnings: EPS Misses Estimates, Stock Declines on Weak ResultsRetail Earnings Report - newsline.com
Personalis (NASDAQ: PSNL) director receives 6,250 RSU award in Form 4/A update - Stock Titan
Lightspeed funds (NASDAQ: PSNL) report 5.8% Personalis stake after in-kind distributions - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: Loss Wider Than Expected, Stock DipsPost-Announcement Reaction - newsline.com
Personalis blood collection kits receive EU regulatory approval - Investing.com UK
Personalis (PSNL) Receives CE Mark Approval for Blood Collection Kits - GuruFocus
Personalis Gains EU Approval for Blood Collection Kits Used in Genomic Testing - Moomoo
Personalis blood collection kits receive EU regulatory approval By Investing.com - Investing.com Nigeria
Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits - Business Wire
Personalis, Inc. Hits Day Low of $10.39 Amid Price Pressure - MarketsMojo
Personalis, Inc. Hits New 52-Week High of $11.84, Up 763.64% - MarketsMojo
Personalis CFO Aaron Tachibana sells $480,400 in company stock By Investing.com - Investing.com India
Personalis CFO Aaron Tachibana sells $480,400 in company stock - Investing.com UK
Personalis (NASDAQ: PSNL) CFO sells 40,000 shares under 10b5-1 plan - Stock Titan
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates Amid Revenue Reporting GapsNegative Surprise Momentum - newsline.com
Aaron L. Tachibana (PSNL) exercises 40,000 options; prior 38,799 10b5-1 sale - Stock Titan
Personalis CEO Sells 100,000 Company Shares Worth $1.1 Million. What Does That Mean for Investors? - The Globe and Mail
Personalis Inc. (PSNL) Q1 2026 Earnings: EPS Misses Estimates as Stock DeclinesEPS Estimate Trend - newsline.com
Personalis Data Highlights Early Cancer Recurrence Detection - Clinical Lab Products
Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 - BioSpace
Assessing Personalis (PSNL) Valuation After Its Strong Recent Share Price Momentum - Yahoo Finance
Personalis Insider Sold Shares Worth $449,292, According to a Recent SEC Filing - marketscreener.com
Personalis CFO and COO Aaron Tachibana sells $449,292 in stock By Investing.com - Investing.com South Africa
Personalis CEO Christopher M. Hall sells $1.1m in stock By Investing.com - Investing.com India
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.76%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):